Nevada health insurance policies to include STI testing and unlimited condom coverage

On April 24, 2025, the Nevada State Legislature introduced Assembly Bill 522, a significant piece of legislation aimed at enhancing healthcare access and affordability for residents. The bill primarily focuses on prescription drug use and mandates comprehensive coverage for sexually transmitted disease (STD) testing and treatment, as well as unrestricted access to condoms for individuals aged 13 and older.

Key provisions of AB522 include the requirement for health insurance policies to cover testing and treatment for STDs such as Chlamydia, gonorrhea, syphilis, HIV, and hepatitis B and C, without imposing age restrictions. Additionally, the bill prohibits insurers from imposing higher deductibles, copayments, or waiting periods for these benefits. It also bars insurers from penalizing healthcare providers who offer these services or from incentivizing them to limit access to such benefits.

The introduction of AB522 has sparked notable discussions among lawmakers and stakeholders. Proponents argue that the bill addresses critical public health issues by ensuring that all individuals, regardless of age, have access to necessary health services without financial barriers. They emphasize the importance of preventive care in reducing the spread of STDs and improving overall community health.

Opposition to the bill has emerged from some insurance industry representatives who express concerns about the potential financial implications for insurers. They argue that the mandated coverage could lead to increased premiums and strain on the healthcare system. However, supporters counter that the long-term benefits of preventive care and reduced healthcare costs associated with untreated STDs outweigh these concerns.

The implications of AB522 extend beyond healthcare access; they touch on broader social and economic issues. By facilitating access to essential health services, the bill aims to improve public health outcomes, potentially reducing the burden on healthcare facilities and lowering overall healthcare costs in the state.

As the legislative process unfolds, AB522 is poised to be a focal point of debate in Nevada, with potential ramifications for healthcare policy and public health initiatives. The bill's progress will be closely monitored by both advocates and opponents as it moves through the legislative agenda.